Vassilios Papadopoulos, DPharm, PhD, Professor, Dept of Medicine; Canada Research Chair in Biochemical Pharmacology; Dr. Phil Gold Chair in Medicine

Secondary Axis: 
Neurosciences
Research Focus: 

Research in my laboratory focuses on understanding the cellular and molecular mechanisms responsible for the initiation and maintenance of steroid biosynthesis in the gonads, adrenal, and brain, in health and disease. We also study the regulation of steroid biosynthesis, intracellular compartmentalization of cholesterol by hormones, chemicals, drugs and environmental factors. Our goals are (i) to understand the pathophysiology of steroidogenesis, (ii) develop new tools for the treatment of diseases related to elevated or low steroid levels, and (iii) alter subcellular steroid compartmentalization as a means to block disease acquisition and/or progression. In these studies we are using biochemical, pharmacological, and molecular methods as well animal models of disease and human specimens to identify the pathophysiological role of critical components of the steroidogenic pathway. Drug design methods and molecular modeling help us modify existing chemical entities and generate novel ones targeted at key elements of the steroidogenic machinery.

Keywords: 
Steroids, neurosteroids, drug discovery, reproductive endocrinology, reproductive toxicology, neuropharmacology, cancer biology
Location: 
Montreal General Hospital
Publications:
Rammouz G, Lecanu L, Aisen P, Papadopoulos V. A lead study on oxidative stress-mediated dehydroepiandrosterone formation in serum: the biochemical basis for a diagnosis of Alzheimer's disease. Journal of Alzheimer’s Disease, 24 (S2):5-16; 2011
Midzak A, Akula N, Lecanu L, Papadopoulos V. A novel androstenetriol interacts with the mitochondrial Translocator protein and controls steroidogenesis. J Biological Chemistry, 286:9875-9887; 2011
Midzak A, Rone M, Aghazadeh Y, Culty M, Papadopoulos V. Mitochondrial protein import and the genesis of steroidogenic mitochondria. Molecular Cellular Endocrinology, 336:70-79; 2011
Tillement L, Lecanu L, Papadopoulos V. Further evidence on mitochondrial targeting of β-amyloid and specificity of β-amyloid-induced mitotoxicity in neurons. Neurodegenerative Diseases, 8:331-344; 2011
Martinez–Arguelles DB, Guichard T, Culty M, Zirkin BR, Papadopoulos V. In utero exposure to the antiandrogen di-(2-ethylhexyl) phthalate decreases adrenal aldosterone production in the adult. Biology of Reproduction, 85:51-61; 2011
Fan J, Liu J, Culty M, Papadopoulos V. Acyl-coenzyme A binding domain containing protein ACBD3 (GCP60/PAP7): a new emerging signaling molecule. Progress in Lipid Research, 49:218-234; 2010
Lecanu L, McCourty A, Sidahmed EK, Greeson J, Papadopoulos V. Caprospinol reduces amyloid deposits and restores cognitive function. Neuroscience, 165:427-435; 2010
Batarseh A, Li J, Papadopoulos V. Protein kinase Cε regulation of translocator protein (18-kDa) Tspo gene expression is mediated through a MAPK pathway targeting STAT3 and c-Jun transcription factors. Biochemistry, 49:4766-4778; 2010
Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, Adams D, Groyer G, Schumacher M. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nature Drug Discovery Reviews, 9:971-988; 2010
Fan J, Traore, K, Li W, Amri H, Huang H, Wu C, Chen H, Zirkin B, Papadopoulos V. Molecular mechanisms mediating the effect of mono- (2-ethylhexyl) phthalate (MEHP) on hormone-stimulated steroidogenesis in MA-10 mouse tumor Leydig cells. Endocrinology, 151:3348-3362; 2010

Articles

News Releases

Breakthroughs in Alzheimer’s and orthopedic surgery included in annual ranking

... read more

MUHC study identifies procedure that detects early stages. New blood test that will diagnose Alzheimer’s disease may soon hit the market.

... read more

JMSB partners with the RI-MUHC to teach business to science grads

... read more